Ann: Medlab Receives AusIndustry Overseas (R&D) Finding Approval, page-5

First 5 Last

Share
Profile

Follow
aani

140 Posts.

18

03/11/21

15:33

Post #: 57288410
Share

Originally posted by Apse: ↑

Essentially means nearly $12m cash rebate over the next 3 years, about equal to 1/4 of the current market cap, without a need to dilute.

MDC will spend what they need to (est ~$27m) to complete NanaBis development including p3 trials overseas, but now get 43.5c back for every dollar spent. If it's like other R&D rebates in Australia, that should flow into the coffers each year, effectively funding toward the next year. I'm not suggesting we'll never see another cap raise but this should have a very significant impact on capital requirements moving forward.

A huge boon for an already heavily undervalued company - recent broker coverage from Blue Ocean Equities valued them at 58c, but the market continues to sleep on this one.

If/when NanaBis comes to market, it will potentially address a multi billion dollar commercial market. Nothing is certain, particularly in biotech, but the risk/reward on this company is becoming ludicrous imo.

Expand

unlikely this trial can be completed without CR. Unless nanocelle commercialisation accelerates which has been painfully slow

MDC Price at posting: 15.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights: Trigg; Droneshield; Lumos & more

Week 29 Wrap: ASX hits new all time high of 8,766pts ahead of Aug 1

STN

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

AII

A new NASDAQ listing for a key player in the global critical minerals space

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

BDM

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

SYR

Syrah jumps +19% as graphite tariff threat spurs optimism down under

SER

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

DRO

History repeats for DroneShield investors but carnage so far subdued

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Ann: Medlab Receives AusIndustry Overseas (R&D) Finding Approval, page-5

Top Stories

HotCopper Highlights: Trigg; Droneshield; Lumos & more

Week 29 Wrap: ASX hits new all time high of 8,766pts ahead of Aug 1

Saturn brings up seventh straight Apollo Hill upgrade on 'impressive' 300-hole drill run

A new NASDAQ listing for a key player in the global critical minerals space

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

Burgundy plunges -20% after turning to layoffs to navigate record-low diamond prices

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Syrah jumps +19% as graphite tariff threat spurs optimism down under

Strategic Energy extends its QLD copper-gold frontier with Diamantina acquisition

History repeats for DroneShield investors but carnage so far subdued

Featured News